Description

Rabbat et al identified factors associated with survival for patients with acute myeloid leukemia (AML) admitted to the intensive care unit (ICU). These can help identify a patient who may benefit from more aggressive management. The authors are from Hopital Hotel Dieu in Paris.


 

Outcomes:

(1) survival to ICU discharge

(2) survival at 1 year after discharge

 

NOTE: A patient with a very high risk of death would not be admitted to the ICU (see previous section).

 

Factors associated with ICU survival:

(1) low to intermediate SAPS II score within 24 hours of ICU admission (see 30.11.02; mean for survivors was 43 with standard deviation 16; mean for nonsurvivors 79 with standard deviation 27)

(2) not using invasive mechanical ventilation (either absence of respiratory failure or use of noninvasive ventilation)

 

Number of Risk Factors Present

Mortality Rate

0

0%

1

38%

2

73%

 

Factors associated with survival at 1 year if discharged from ICU alive:

(1) achievement of complete remission

(2) AML Type 3 (FAB classification, promyelocytic)

(3) age <= 60 years

(4) ECOG performance status 0 or 1

 

In multivariate analysis only the achievement of complete remission was an independent predictor for 1 year survival.

 


To read more or access our algorithms and calculators, please log in or register.